CLFD vs JAZZ · P/E 196, rev $150.1M vs P/E 1988, rev $4.07B
Clearfield Inc (CLFD) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Clearfield Inc (CLFD) is a communication equipment company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported CLFD revenue for 2025-09-30 was $150.1M. Net income was -$8.1M. Revenue was up 19.6% from 2024-09-30 to 2025-09-30. CLFD currently screens at market cap $613.3M and trailing P/E 196.2.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
CLFD currently screens at market cap $613.3M and trailing P/E 196.2. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the CLFD and JAZZ stock pages for the full models.
Not investment advice.